Unique ID issued by UMIN | UMIN000031119 |
---|---|
Receipt number | R000035528 |
Scientific Title | clinical evaluation trial about prediction of treatment effect of chemotherapy or chemoradiotherapy for gastrointestinal cancer using oxygen saturation imaging endoscopy |
Date of disclosure of the study information | 2018/02/02 |
Last modified on | 2018/02/02 16:01:43 |
clinical evaluation trial about prediction of treatment effect of chemotherapy or chemoradiotherapy for gastrointestinal cancer using oxygen saturation imaging endoscopy
clinical evaluation trial using OSI endoscopy
clinical evaluation trial about prediction of treatment effect of chemotherapy or chemoradiotherapy for gastrointestinal cancer using oxygen saturation imaging endoscopy
clinical evaluation trial using OSI endoscopy
Japan |
esophageal cancer, gastric cancer, and colorectal cancer
Gastroenterology |
Malignancy
YES
To evaluate the clinical efficacy of oxygen saturation imaging endoscopy about prediction of treatment efficacy of chemotherapy or chemoradiotherapy for gastrointestinal cancer.
Efficacy
correlation between oxygen saturation of tissue surface before chemotherapy or chemoradiotherapy evaluated with oxygen saturation imaging and treatment efficacy
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Diagnosis
Device,equipment |
oxygen saturation imaging
20 | years-old | <= |
Not applicable |
Male and Female
1) >= 20 years old.
2) ECOG performance status of <= 2.
3) Written informed consent.
4) The following treatments are scheduled for esophageal, gastric, or colorectal advanced cancer.
a. Neoadjuvant chemotherapy with DCF regimen and surgery scheduled for esophageal cancer.
b. Definitive chemoradiotherapy scheduled for esophageal cancer.
c. Initial chemotherapy scheduled for unresectable gastric cancer.
d. Initial chemotherapy scheduled for unresectable colorectal cancer.
1) Psychosis.
2) Ileus, obstruction or perforation of the digestive tract has been diagnosed or is suspected.
3) Active bacterial or fungal infection.
4) History of myocardial infarction or unstable angina pectoris within three months.
5) Ineligible judged by attending doctor.
70
1st name | |
Middle name | |
Last name | Tomonori Yano |
National Cancer Center Hospital East
Department of Gastroenterology and Endoscopy
6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
04-7133-1111
toyano@east.ncc.go.jp
1st name | |
Middle name | |
Last name | Yusuke Yoda |
National Cancer Center Hospital East
Department of Gastroenterology and Endoscopy
6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan
04-7133-1111
yuyoda@east.ncc.go.jp
National Cancer Center Hospital East
National Cancer Center
Other
NO
国立がん研究センター東病院(千葉県)
2018 | Year | 02 | Month | 02 | Day |
Unpublished
Preinitiation
2017 | Year | 11 | Month | 16 | Day |
2018 | Year | 02 | Month | 02 | Day |
2018 | Year | 02 | Month | 02 | Day |
2018 | Year | 02 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035528
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |